In addition to the MAPK and NF-κB pathways, the AMP-activated protein kinase (AMPK) and mTOR signaling pathways are intricately linked to the development and regulation of obesity, making them potential targets for therapeutic intervention [14, 32]. This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.